Interstitial Lung Disease Remains Major a Diagnostic Challenge


pf_major challenge

Veracyte, Inc.recently presented four abstracts on current diagnostic challenges related to interstitial lung disease (ILD) and the potential for improved diagnostic procedures using novel genomic-based strategies. The abstracts were given at the Pulmonary Fibrosis Foundation’s PFF Summit 2015: From Bench to Bedside at the JW Marriott Hotel in Washington, D.C., in November.

Read more:

How useful was this post?

Click on a star to rate it!

Average rating 3 / 5. Vote count: 2

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

One comment

  1. I was diagnosed with IPF in 2008, one month after my older brother died of it. He had had open heart surgery approximately 5 yrs before & had RA. He never smoked. In 2002 I was diagnosed with MCTD (unspecified). I hadn’t smoked for approx 30 yrs prior to 2008. I’m almost 82 now and al- though my disease is progressively worse, I’m on oxygen 24/7, CPAP, mycophenolic 360mg 4 per day, Prednisone 7.5mg per day, Aggrenox 25/200mg 2 per day, 7 stents (6 in RCA 1996, 1 in 2005). I don’t feel like an ‘ill’ person, but fatigue seems to be my big complaint. Have good Drs and so far so good, lol. My uneducated opinion is there is no difference in IPF & what I have!?!

Leave a Comment

Your email address will not be published. Required fields are marked *